Lantheus (LNTH)
(Delayed Data from NSDQ)
$82.87 USD
+3.20 (4.02%)
Updated May 20, 2024 04:00 PM ET
4-Sell of 5 4
B Value A Growth B Momentum A VGM
Lantheus Holdings (LNTH) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$102.63 | $110.00 | $96.00 | 23.84% |
Price Target
Based on short-term price targets offered by eight analysts, the average price target for Lantheus Holdings comes to $102.63. The forecasts range from a low of $96.00 to a high of $110.00. The average price target represents an increase of 23.84% from the last closing price of $82.87.
Analyst Price Targets (8 )
Broker Rating
Lantheus Holdings currently has an average brokerage recommendation (ABR) of 1.22 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by nine brokerage firms. The current ABR compares to an ABR of 1.22 a month ago based on nine recommendations.
Of the nine recommendations deriving the current ABR, eight are Strong Buy, representing 88.89% of all recommendations. A month ago, Strong Buy represented 88.89%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 8 | 8 | 8 | 8 | 8 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.22 | 1.22 | 1.22 | 1.22 | 1.22 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
5/3/2024 | Mizuho SecuritiesUSA | Anthony Petrone | Strong Buy | Strong Buy |
5/3/2024 | Truist Securities | Richard Newitter | Strong Buy | Strong Buy |
5/2/2024 | William Blair | Andy T Hsieh | Hold | Hold |
4/19/2024 | B. Riley Securities | Yuan Zhi | Strong Buy | Strong Buy |
2/23/2024 | JMP Securities | David L Turkaly | Strong Buy | Strong Buy |
1/11/2024 | SVB Securities | Roanna Ruiz | Strong Buy | Strong Buy |
11/30/2023 | Brookline Capital Markets | Kemp Dolliver | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.22 |
ABR (Last week) | 1.22 |
# of Recs in ABR | 9 |
Average Target Price | $102.63 |
LT Growth Rate | NA |
Industry | Medical - Products |
Industry Rank by ABR | 93 of 252 |
Current Quarter EPS Est: | 1.66 |